The FDA Advisory Committee meeting is scheduled for July 30 ... the Company’s lead cell therapy candidate with a Biologics License Application (BLA) under FDA review for potential approval ...

Capricor Therapeutics' rating was downgraded amid FDA inspection risks, regulatory uncertainty, and potential delays in ...

U.S. FDA successfully completed Pre-License Inspection; Company expects facility will meet all requirements to support ...

Capricor Therapeutics (CAPR) announced the completion of the Food and Drug Administration’s pre-license inspection of its San ...

Investing.com -- Capricor Therapeutics Inc (NASDAQ: CAPR) stock tumbled 10.5% after the company announced that the FDA’s inspection of its San Diego manufacturing facility resulted in a Form 483 with ...

Kennedy has fired all 17 members of a U.S. Centers for Disease Control and Prevention panel of vaccine experts and is in the ...

H.C. Wainwright notes that Capricor Therapeutics (CAPR) announced that the FDA has completed its pre-license inspection of the company’s San Diego ...

Here's what to know about Health and Human Services Secretary Robert F. Kennedy, Jr. retiring the panel's 17 members.

An FDA advisory committee due to be held in March to discuss the formulation of influenza vaccines for the 2025/26 flu season has been cancelled, according to US reports. The meeting of the ...

This week, it was a case of mixed fortunes for pharma companies in FDA advisory committee meetings, as experts backed one cancer drug application from Johnson & Johnson but voted against three ...

The Advisory Committee on Immunization Practices guides the CDC’s hand on vaccine policy, but some of its new members have ...